171 related articles for article (PubMed ID: 33579550)
1. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients.
O'Leary JG; Philippe A; Freeman R; Heidecke H; Jennings LW; Catar R; Klintmalm GB; Dragun D
Transplant Proc; 2021 Apr; 53(3):1019-1024. PubMed ID: 33579550
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
El Band JEK; Llorente S; Martinez-Garcia P; Alfaro R; Jimenez-Coll V; Boix F; Galián JA; Martinez-Banaclocha H; Botella C; Moya-Quiles MR; Minguela A; Legaz I; Muro M
Curr Protein Pept Sci; 2021; 22(10):745-757. PubMed ID: 34967284
[TBL] [Abstract][Full Text] [Related]
3. Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Zmonarski S; Mazanowska O; Krajewska M; Bartoszek D; Zabińska M; Myszka M; Kamińska M; Hałoń A; Dawiskiba T; Szyber P; Sas A; Klinger M
Transplant Proc; 2014 Oct; 46(8):2618-21. PubMed ID: 25380879
[TBL] [Abstract][Full Text] [Related]
4. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
[TBL] [Abstract][Full Text] [Related]
5. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
[TBL] [Abstract][Full Text] [Related]
6. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
Pearl MH; Chen L; Zuckerman JE; Weng PL; Chambers ET; Zhang Q; Reed EF
Transplantation; 2024 Jan; 108(1):276-283. PubMed ID: 37527494
[TBL] [Abstract][Full Text] [Related]
7. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
Liu C; Kang ZY; Yin Z; Xiao Y; Liu W; Zhao Y; Li DH
Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
[TBL] [Abstract][Full Text] [Related]
8. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Krajewska M; Mazanowska O; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Dawiskiba T; Chudoba P; Klinger M
Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747
[TBL] [Abstract][Full Text] [Related]
9. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
[TBL] [Abstract][Full Text] [Related]
10. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
[TBL] [Abstract][Full Text] [Related]
11. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
Giral M; Foucher Y; Dufay A; Duong Van Huyen JP; Renaudin K; Moreau A; Philippe A; Hegner B; Dechend R; Heidecke H; Brouard S; Cesbron A; Castagnet S; Devys A; Soulillou JP; Dragun D
Am J Transplant; 2013 Oct; 13(10):2567-76. PubMed ID: 23919486
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
[TBL] [Abstract][Full Text] [Related]
13. Pre-transplant AT
Gareau AJ; Wiebe C; Pochinco D; Gibson IW; Ho J; Rush DN; Nickerson PW
Transpl Immunol; 2018 Feb; 46():29-35. PubMed ID: 29217423
[TBL] [Abstract][Full Text] [Related]
14. Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.
Pearl MH; Leuchter RK; Reed EF; Zhang Q; Ettenger RB; Tsai EW
Pediatr Nephrol; 2015 Aug; 30(8):1371-4. PubMed ID: 25956702
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation.
Lee J; Huh KH; Park Y; Park BG; Yang J; Jeong JC; Lee J; Park JB; Cho JH; Lee S; Ro H; Han SY; Kim MS; Kim YS; Kim SJ; Kim CD; Chung W; Park SB; Ahn C;
Nephrol Dial Transplant; 2017 Jul; 32(7):1244-1250. PubMed ID: 26546592
[TBL] [Abstract][Full Text] [Related]
16. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Nephrology (Carlton); 2019 Mar; 24(3):347-356. PubMed ID: 29451342
[TBL] [Abstract][Full Text] [Related]
17. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
Front Immunol; 2021; 12():786039. PubMed ID: 34956217
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies.
Civieri G; Iop L; Tona F
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055116
[TBL] [Abstract][Full Text] [Related]
19. Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation.
Hiemann NE; Meyer R; Wellnhofer E; Schoenemann C; Heidecke H; Lachmann N; Hetzer R; Dragun D
Transplantation; 2012 Nov; 94(9):919-24. PubMed ID: 23034559
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
Abuzeineh M; Aala A; Alasfar S; Alachkar N
BMC Nephrol; 2020 Jul; 21(1):253. PubMed ID: 32615995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
